Cargando…
Targeted Radionuclide Therapy: New Advances for Improvement of Patient Management and Response
Compared to external beam radiotherapy, targeted radionuclide therapy (TRT) allows for systemic radiation treatment of metastatic lesions. Published work on recent strategies to improve patient management and response to TRT through individualising patient treatment, modifying treatment pharmacokine...
Autores principales: | Malcolm, Javian, Falzone, Nadia, Lee, Boon Q., Vallis, Katherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406485/ https://www.ncbi.nlm.nih.gov/pubmed/30823564 http://dx.doi.org/10.3390/cancers11020268 |
Ejemplares similares
-
Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability
por: Falzone, Nadia, et al.
Publicado: (2019) -
Subcellular Targeting of Theranostic Radionuclides
por: Bavelaar, Bas M., et al.
Publicado: (2018) -
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [(177)Lu]Lu-DOTATATE
por: Malcolm, Javian C., et al.
Publicado: (2022) -
Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
por: Falzone, Nadia, et al.
Publicado: (2018) -
Radiosensitivity of colorectal cancer to (90)Y and the radiobiological implications for radioembolisation therapy
por: Lee, Boon Q, et al.
Publicado: (2019)